RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Regenerative Medical Technology Group Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026
- Market cap
- $497.25K
- P/E (TTM)
- –
- Dividend yield
- –
Regenerative Medical Technology Group Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Stem Cells Group [Member] | $9.41M | – | $5.10M | – | – | – | – | – | – | – | – | – | 100.0% | – |
| Product supplies [Member] | $4.36M | $2.66M | $2.02M | $1.89M | $2.01M | $2.02M | $1.75M | $1.58M | $1.47M | $1.25M | $1.33M | $1.30M | 46.4% | +117.2% |
| Training [Member] | $2.91M | $1.75M | $1.13M | $1.07M | $821.71K | $844.24K | $809.65K | $537.94K | $575.79K | $528.44K | $599.43K | $542.01K | 30.9% | +254.5% |
| Patient procedures [Member] | $2.07M | $1.88M | $1.87M | $2.02M | $1.93M | $1.71M | $1.37M | $962.31K | $673.34K | $495.89K | $319.00K | – | 21.9% | +7.0% |
| Equipment [Member] | – | – | $75.84K | – | – | – | $177.23K | $128.12K | $154.69K | $165.49K | $162.37K | – | – | – |
By region
From the segment and revenue-disaggregation notes of Regenerative Medical Technology's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.